Last reviewed · How we verify
NCT05325996
Evaluating Home Testing Devices for the Management of Glaucoma
NA trial testing Standard Automatic Perimetry Humphrey Field Analyzer in Glaucoma, Open-Angle in 53 participants. Completed in 17 February 2025.
17 February 2025
Quick facts
| Lead sponsor | Wills Eye |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 53 |
| Start date | 15 April 2022 |
| Primary completion | 17 February 2025 |
| Estimated completion | 17 February 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Standard Automatic Perimetry Humphrey Field Analyzer
- visuALL H
- iCare Home Tonometer
- Spectralis Optical coherence tomography (OCT)
Conditions studied
- Glaucoma, Open-Angle — all drugs for Glaucoma, Open-Angle →
Sponsor
Wills Eye — full company profile →
Who can join
Adults 20 to 80, any sex, with Glaucoma, Open-Angle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05325996
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard Automatic Perimetry Humphrey Field Analyzer
Trials testing the same drug.
- NCT03804684 — visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry · NA · completed
Other recruiting trials for Glaucoma, Open-Angle
Currently open trials in the same condition.
- NCT06964191 — Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension · Phase 2 · recruiting
- NCT06240312 — Optic Nerve Head Strain as Biomarker for Glaucoma · NA · recruiting
- NCT05405868 — Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial · Phase 3 · recruiting
- NCT05710198 — Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma · Phase 3 · recruiting
- NCT06058598 — Exercise Training in Patients With Glaucoma · NA · active not recruiting
Other Wills Eye trials
Trials by the same sponsor.
- NCT05660447 — A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR · Phase 2, PHASE3 · active not recruiting
- NCT06130384 — Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection. · Phase 4 · completed
- NCT04784234 — Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin · NA · terminated
- NCT04459949 — Comparative Study of Sharkskin Versus Grieshaber Forceps During ILM Peeling · NA · unknown
- NCT04202510 — IOP and Medication Reduction in MIGS Procedures · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05325996 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wills Eye
- Last refreshed: 14 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05325996.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing